The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-18 of 18 articles
Preprocedural physiological assessment of coronary disease patterns to predict haemodynamic outcomes post-PCI
Kotoku N,
Ninomiya K,
Masuda S,
O’Leary N,
Garg S,
Naito M,
Miyashita K,
Tobe A,
Kageyama S,
Tsai TY,
Revaiah PC,
Tu S,
Kozuma K,
Kawashima H,
Ishibashi Y,
Nakazawa G,
Takahashi K,
Okamura T,
Miyazaki Y,
Tateishi H,
Nakamura M,
Kogame N,
Asano T,
Nakatani S,
Morino Y,
Ishida M,
Katagiri Y,
Ono M,
Hara H,
Sotomi Y,
Tanabe K,
Ozaki Y,
Muramatsu T,
Dijkstra J,
Onuma Y,
Serruys PW
November 14, 2023 | 10.4244/EIJ-D-23-00516
Statistical methods for composite endpoints
Hara H,
van Klaveren D,
Kogame N,
Chichareon P,
Modolo R,
Tomaniak M,
Ono M,
Kawashima H,
Takahashi K,
Capodanno D,
Onuma Y,
Serruys PW
April 2, 2021 | 10.4244/EIJ-D-19-00953
Online three-dimensional OFDI-guided versus angiography-guided PCI in bifurcation lesions: design and rationale of the randomised OPTIMUM trial
Miyazaki Y,
Muramatsu T,
Asano T,
Katagiri Y,
Sotomi Y,
Nakatani S,
Takahashi K,
Kogame N,
Higuchi Y,
Ishikawa M,
Kyono H,
Yano M,
Ozaki Y,
Serruys PW,
Okamura T,
Onuma Y
March 19, 2021 | 10.4244/EIJ-D-18-00902
A randomised controlled trial of the sirolimus-eluting biodegradable polymer ultra-thin Supraflex stent versus the everolimus-eluting biodegradable polymer SYNERGY stent for three-vessel coronary artery disease: rationale and design of the Multivessel TALENT trial
Hara H,
Gao C,
Kogame N,
Ono M,
Kawashima H,
Wang R,
Morel M,
O'Leary N,
Sharif F,
Möllmann H,
Reiber J,
Sabaté M,
Zaman A,
Wijns W,
Onuma Y,
Serruys PW
December 18, 2020 | 10.4244/EIJ-D-20-00772
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial
Takahashi K,
Chichareon P,
Modolo R,
Kogame N,
Chang C,
Tomaniak M,
Moschovitis A,
Curzen N,
Haude M,
Jung W,
Holmvang L,
Garg S,
Tijssen J,
Wykrzykowska JJ,
de Winter R,
Hamm C,
Steg G,
Stoll H,
Onuma Y,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys PW
October 23, 2020 | 10.4244/EIJ-D-19-00498
Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study
Asano T,
Kogame N,
Onuma Y,
Modolo R,
Chichareon P,
Lefèvre T,
Legutko J,
Digne F,
Morel M,
Serruys PW,
Gil R
October 23, 2020 | 10.4244/EIJ-D-19-00361
Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial
Tomaniak M,
Chichareon P,
Modolo R,
Takahashi K,
Chang C,
Kogame N,
Spitzer E,
Buszman P,
van Geuns R,
Valkov V,
Steinwender C,
Geisler T,
Prokopczuk J,
Sabaté M,
Zmudka K,
Rademaker-Havinga T,
Tijssen J,
Jüni P,
Hamm C,
Steg G,
Onuma Y,
Vranckx P,
Valgimigli M,
Windecker S,
Baber U,
Anderson R,
Dominici M,
Serruys PW
April 3, 2020 | 10.4244/EIJ-D-19-00699
Clinical outcomes of bioabsorbable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: two-year follow-up of the DESSOLVE III trial
Katagiri Y,
Onuma Y,
Lurz P,
Buszman P,
Piek J,
Wykrzykowska JJ,
Asano T,
Kogame N,
Takahashi K,
Chang C,
de Winter R,
Serruys PW,
Wijns W
February 7, 2020 | 10.4244/EIJ-D-18-00944
Defining device success for percutaneous coronary intervention trials: a position statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology
Chang C,
Kogame N,
Onuma Y,
Byrne RA,
Capodanno D,
Windecker S,
Morel M,
Cutlip D,
Krucoff M,
Stone GW,
Lansky AJ,
Mehran R,
Spitzer E,
Fraser A,
Baumbach A,
Serruys PW
January 17, 2020 | 10.4244/EIJ-D-19-00552
Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial
Serruys PW,
Tomaniak M,
Chichareon P,
Modolo R,
Kogame N,
Takahashi K,
Chang C,
Spitzer E,
Walsh S,
Adlam D,
Hildick-Smith D,
Édes I,
van de Harst P,
Krackhardt F,
Tijssen J,
Rademaker-Havinga T,
Garg S,
Steg G,
Hamm C,
Jüni P,
Vranckx P,
Onuma Y,
Verheugt F
December 20, 2019 | 10.4244/EIJ-D-19-00202
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial
Chichareon P,
Onuma Y,
van Klaveren D,
Modolo R,
Kogame N,
Takahashi K,
Chang C,
Tomaniak M,
Asano T,
Katagiri Y,
van Geuns R,
Bolognese L,
Tumscitz C,
Vrolix M,
Petrov I,
Garg S,
Naber C,
Sabaté M,
Iqbal J,
Wykrzykowska JJ,
Piek J,
Spitzer E,
Jüni P,
Hamm C,
Steg G,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys PW
August 9, 2019 | 10.4244/EIJ-D-19-00184
Prasugrel monotherapy after PCI with the SYNERGY stent in patients with chronic stable angina or stabilised acute coronary syndromes: rationale and design of the ASET pilot study
Kogame N,
Modolo R,
Tomaniak M,
Cavalcante R,
de Martino F,
Tinoco J,
Ribeiro E,
Mehran R,
Campos C,
Onuma Y,
Lemos P,
Serruys PW
August 9, 2019 | 10.4244/EIJ-D-19-00131
A prospective multicentre randomised all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX: rationale and design of the Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent (TALENT) trial
Modolo R,
Chichareon P,
Kogame N,
Asano T,
Chang C,
de Winter R,
Kaul U,
Zaman A,
Spitzer E,
Takahashi K,
Katagiri Y,
Soliman O,
Van Es G-A,
Morel M,
Onuma Y,
Serruys PW
July 19, 2019 | 10.4244/EIJ-D-18-00499
Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study
Serruys PW,
Farooq V,
Banning AP,
Escaned J,
Wykrzykowska JJ,
Piek J,
Dudek D,
Ochala A,
Hildick-Smith D,
Goicolea J,
Iñiguez A,
Buszman P,
Modolo R,
Katagiri Y,
Kogame N,
Onuma Y
June 12, 2019 | 10.4244/EIJ-D-18-00980
Interventional cardiology 2018: the year in review
Komiyama H,
Modolo R,
Chang C,
Chichareon P,
Kogame N,
Takahashi K,
Tomaniak M,
Onuma Y,
Cuisset T,
Fajadet J,
Amin H,
Al Rashdan I,
Serruys PW
April 5, 2019 | 10.4244/EIJ-D-19-00040
A randomised comparison of healing response between the BuMA Supreme stent and the XIENCE stent at one-month and two-month follow-up: PIONEER-II OCT randomised controlled trial
Asano T,
Jin Q,
Katagiri Y,
Kogame N,
Takahashi K,
Chang C,
Chichareon P,
Wang C,
Shi B,
Su X,
Fu G,
Wu Y,
Zhou X,
Yuan Z,
Wykrzykowska JJ,
Piek J,
Serruys PW,
Onuma Y,
Chen Y
December 20, 2018 | 10.4244/EIJ-D-18-00461
Latest news
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
PCR London Valves 2023
November 16, 2023
NEW ISSUE
PCR London Valves special edition. State-of-the-art on TMVI; the timing of TMVI; direct wire pacing for TMVR; predicting patient-prosthesis mismatch following TAVI and more
November 17, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
AHEAD OF PRINT
Cardiac damage classification in each AS subtype
FREE ARTICLE - Masaaki Nakase et al
November 6, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023
AHEAD OF PRINT
CAPTIS embolic protection during TAVR
FREE ARTICLE - Haim D. Danenberg et al
November 2, 2023